Home | Medical-Newswire.Com:
(Medical-NewsWire.com, December 07, 2017 ) According to the report, the Global Biomarkers industry, published by the Market Data Forecast. The Global industry has been expected to reach USD 46.12 billion by 2020 from USD 24.55 billion in 2015, growing at a CAGR of 13.44% during the forecast period 2015-2020.
Biomarkers are described as the biological molecules or genes assist in crucial clinical decisions and diagnosis of health conditions in patients. These are also known as molecular markers or signature molecules and used to analyze the pharmacologic responses, biological & pathological conditions. Biomarkers are found extensively in body fluids and tissues. Biomarkers are helpful in drug discovery & development processes and assessment of disease conditions.
Browse industry data tables and in-depth TOC of Global Biomarkers industry report to 2020 @ http://www.marketdataforecast.com/market-reports/global-biomarkers-market-192/
Increasing research & development spending, rising healthcare expenditure, and growing demand for biomarkers in diagnostic field are driving the growth of Global biomarkers industry. In addition, increasing number of low cost of clinical trials in emerging countries, growing initiatives in biomarkers research, increasing growth of information technology, growing demand for drug discovery are further propelling the growth of Global biomarkers industry. However, requirement of high investment, improper reimbursement policies, poor regulatory bodies, high cost of testing procedures, and difficulties in sample collection & storage are the major factors restraining the growth of Global biomarkers industry.
Global biomarkers industry is segmented based on the product, type, application, and disease indications. Based on product, the market is further sub-segmented as consumables, software, and services. Based on type, the market is segmented as safety biomarkers, efficacy biomarkers, and validation biomarkers. Biomarkers application is further segmented as diagnostics developments, drug discovery & developments, personalized medicine, and disease risk assessment. Based on disease indications, the market is segmented as cancer, cardiovascular, neurological, and immunological disorders.
Download Free Sample Report @ http://www.marketdataforecast.com/market-reports/global-biomarkers-market-192/request-sample
On the basis of geographical region the Global biomarkers industry is segmented as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America held the major market share of 39.0% of the Global biomarkers industry in 2015, whereas Asia-Pacific is estimated to grow at the highest CAGR of 16.20% during the forecast period 2015-2020.
The key players in Global biomarkers industry include, Bio-Rad Laboratories (U.S.), Qiagen N.V. (Netherlands), Enzo Biochem (U.S.), PerkinElmer, Inc. (U.S.), Merck & Co, Inc. (U.S.), EKF Diagnostics Holdings plc. (U.S.), Meso Scale Diagnostics, LLC (U.S.), Singulex, Inc. (U.S.), BioSims Technologies (France), Cisbio Bioassays (France), and Signosis, Inc. (U.S.).
Inquire Before buying report @ http://www.marketdataforecast.com/market-reports/global-biomarkers-market-192/inquire
Key Points from Table of Contents
•Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
• Industry Segmentation
o By Product
o By Type
o Disease Indications
•Pipeline Product Analysis
•Porter’s Five analysis
•Industry Leaders' Analysis
Avail Discount @ http://www.marketdataforecast.com/market-reports/global-biomarkers-market-192/request-discount
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Market Data Forecast